Modulation of a novel population of immune suppressive tumoural macrophages and the therapeutic vaccination of cancer

Projektinformationen

MacTherVac

ID Finanzhilfevereinbarung: 335326

Projekt abgeschlossen

Startdatum 1 September 2013

Enddatum 31 August 2018

Finanziert unter

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 1 499 994,00

EU-Beitrag € 1 499 994,00

Koordiniert durch

KING'S COLLEGE LONDON
United Kingdom